Understanding the Challenge: Ocular Drug Delivery Ocular diseases such as dry eye, infections, glaucoma, myopia, and fundus disease are often treated with topical medications like eye drops, ointments, and tablets. However, these traditional methods face […]
New Study Explores Deep Learning to Improve Breast Cancer Diagnosis Using Routine CT Scans Breast cancer remains the most common malignancy among women globally and is a major cause of cancer-related death. According to the […]
Understanding Osteoarthritis: A Growing Health Challenge Osteoarthritis (OA) is the most common form of joint disease, characterized by the progressive breakdown of cartilage, changes in the subchondral bone, inflammation of the synovium, and pain leading […]
Understanding the Burden of Community-Acquired Pneumonia Community-acquired pneumonia (CAP) remains one of the leading causes of morbidity and mortality worldwide, particularly among patients admitted to intensive care units (ICUs). Despite the development of advanced antimicrobial […]
Heart failure (HF) is a final common outcome for many cardiovascular diseases and remains a global health challenge. Despite progress in treatment options, HF incidence and mortality rates remain high. At its core, HF reflects […]
Understanding Sensorineural Hearing Loss Sensorineural hearing loss (SNHL) is the most common type of hearing impairment worldwide. According to the World Health Organization, approximately 6% of the global population experiences some form of hearing loss. […]
A meta-analysis Understanding the Impact of Diabetes During Pregnancy Diabetes mellitus (DM) has become one of the most common metabolic disorders worldwide, especially among women of childbearing age. Two major types are seen during pregnancy: […]
Understanding the Stakes: Lung Cancer and the PD-L1 Challenge Lung cancer is the most diagnosed cancer worldwide, with nearly two million new cases reported each year. Among its types, non-small cell lung cancer (NSCLC) dominates […]
New Insights into Glioblastoma’s Immune Evasion: CD44 and TNFSF14 Take Center Stage Glioblastoma (GBM) remains one of the most aggressive and lethal cancers, with a median survival of just 15 months. Despite intensive treatment that […]
New research examines how biomarkers at diagnosis might guide therapy decisions in myelodysplastic syndrome Understanding Myelodysplastic Syndrome Myelodysplastic syndrome (MDS) is a clonal disorder of hematopoietic stem cells. It disrupts the normal formation of blood […]
Copyright (c) 2021 Association of Basic Medical Sciences of FBIH